Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 17Active not recruiting 17Not yet recruiting 8Completed 6Terminated 3Enrolling by invitation 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 29Carboplatin 15Cisplatin 13Nivolumab 12atezolizumab 10Radiotherapy 10Paclitaxel 10Ipilimumab 10venetoclax 9Pemetrexed 9Docetaxel 9durvalumab 8Gemcitabine 8fludarabine 7Specimen Handling 7Cyclophosphamide 7Bevacizumab 7tislelizumab 6fludarabine phosphate 6Trastuzumab 6Practice Guidelines as Topic 6Cetuximab 6Biopsy 6enzalutamide 5Surveys and Questionnaires 5Standard of Care 5Radiosurgery 5Magnetic Resonance Spectroscopy 5Dexamethasone 5Cytarabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Early Intervention, Educational × 90 days × Clear all
NCT04630431 2026-06-04

Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Mayo Clinic

Phase NA Terminated
590 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT05452681 2026-05-07

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

University of Alabama at Birmingham

Phase NA Terminated
27 enrolled
Breast

Breast Neoplasms

NCT05243056 2026-05-06

A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment

University of Alabama at Birmingham

Phase NA Terminated
37 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡